https://www.taxtmi.com/news?id=38412 Sudden reductions in a major donor's contributions have critically disrupted international HIV response financing, threatening increased infections and deaths and prompting contingency planning. The executive director proposes a commercial licensing arrangement allowing broader production and licensing of the HIV prevention drug lenacapavir to expand global access, framed to combine public health impact with commercial incentives and to mitigate funding shortfalls while strengthening delivery mechanisms in low-resource settings. en-us Mon, 24 Mar 2025 21:16:03 +0530 Mon, 24 Mar 2025 21:16:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=38412 Sudden reductions in a major donor's contributions have critically disrupted international HIV response financing, threatening increased infections and deaths and prompting contingency planning. The executive director proposes a commercial licensing arrangement allowing broader production and licensing of the HIV prevention drug lenacapavir to expand global access, framed to combine public health impact with commercial incentives and to mitigate funding shortfalls while strengthening delivery mechanisms in low-resource settings. News - Mon, 24 Mar 2025 21:16:03 +0530 https://www.taxtmi.com/news?id=38412